In Vivo Antitumor Activity of T Cells Redirected with Chimeric Antibody/T-Cell Receptor Genes

Cancer Research

Volumn 55, Issue 15, 1995, Pages 3369-3373

  Hwu, P ^a   Yang, J C ^a   Cowherd, R ^a   Treisman, J ^a   Shafer, G E ^a   Eshhar, Z ^b   Rosenberg, S A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; INTERLEUKIN 2; MONOCLONAL ANTIBODY; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; CHIMERA; COLON ADENOCARCINOMA; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LUNG METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMAL; ANTIBODIES, MONOCLONAL; CHIMERIC PROTEINS; FEMALE; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; INTERLEUKIN-2; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; MICE, NUDE; OVARIAN NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; SARCOMA, EXPERIMENTAL; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029134048     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Rosenberg, S. A., Packard, B. S., Aebersold, P. M., Solomon, D., Topalian, S. L., Toy, S. T., Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., Simpson, C., Carter, C., Bock, S., Schwartzentruber, D., Wei, J. P., and White, D. E. Use of rumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. Preliminary report. N. Engl. J. Med., 319: 1676–1680, 1988.
2. Rosenberg, S. A., Yannelli, J. R., Yang, J. C., Topalian, S. L., Schwartzentruber, D. J., Weber, J. S., Parkinson, D. R., Seipp, C. A., Einhorn, J. H., and White, D. E. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J. Natl. Cancer Inst., 86: 1159–1166, 1994.
3. Kawakami, Y., Zakut, R., Topalian, S. L., Stötter, H., and Rosenberg, S. A. Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J. Immunol., 148: 638–643, 1992.
4. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347–352, 1994.
5. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515–3519, 1994.
6. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91: 6458–6462, 1994.
7. Van Der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., DePlaen, E., Van Den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643–1647, 1991.
8. Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethë, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178: 489–495,1993.
9. Jain, R. K. Delivery of novel therapeutic agents in rumors: physiological barriers and strategies. J. Natl. Cancer Inst., 81: 570–576, 1989.
10. Eshhar, Z., Waks, T., Gross, G., and Schindler, D. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ζ subunits of the immunoglobulin and T-cell receptors. Proc. Natl. Acad. Sci., USA, 90: 720–724, 1993.
11. Hwu, P., Shafer, G. E., Treisman, J., Schindler, D. G., Gross, G., Cowherd, R., Rosenberg, S. A., and Eshhar, Z. Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor γ chain. J. Exp. Med., 178: 361–366, 1993.
12. Orloff, D., Ra, G., Frank, S. J., Klausner, R. D., and Kinet, J-P. Family of disulphide-linked dimers containing the ζ and ηchains of the T-cell receptor and the γ chain of Fc receptors. Nature (Lond.), 347: 189–191, 1990.
13. Letourneur, F., and Klausner, R. D. T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins. Proc. Natl. Acad. Sci. USA, 88: 8905–8909, 1991.
14. Romeo, C., Amiot, M., and Seed, B. Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor ζ chain. Cell, 68: 889–897, 1992.
15. Romeo, C., and Seed, B. Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides. Cell, 64: 1037–1046, 1991.
16. Irving, B. A., and Weiss, A. The cytoplasmic domain of the T cell receptor chain is sufficient to couple to receptor-associated signal transduction pathways. Cell, 64: 891–901, 1991.
17. Coney, L. R., Tomassetti, A., Carayannopoulos, L., Frasca, V., Kamen, B. A., Colnaghi, M. I., and Zurawski, V. R. Cloning of a tumor-associated antigen: MOvl8 and MOvl9 antibodies recognize a folate-binding protein. Cancer Res., 57: 6125–6132, 1991.
18. Miotti, S., Canevari, S., Ménard, S., Mezzanzanica, D., Porro, G., Pupa, S. M., Regazzoni, M., Tagliabue, E., and Colnaghi, M. I. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int. J. Cancer, 39: 297–303, 1987.
19. Kohler, G., and Milstein, C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur. J. Immunol., 6: 511–519, 1976.
20. Ochi, A., Hawlcy, R. G., Hawley, T., and Shulman, M. J. Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells. Proc. Natl. Acad. Sci., USA, 80: 6351–6355, 1983.
21. Miller, A. D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. BioTechniques, 7: 980–988, 1989.
22. Treisman, J., Hwu, P., Minamoto, S., Shafer, G. E., Cowherd, R., Morgan, R., and Rosenberg, S. A. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen. Blood, 85: 139–145, 1995.
23. Miller, A. D., and Buttimore, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol., 6: 2895–2902, 1986.
24. Shiloni, E., Karp, S. E., Custer, M. C., Shilyansky, J., Restifo, N. P., Rosenberg, S. A., and Mule, J. J. Retroviral transduction of interferon-γ cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor. Cancer Immunol. Immunother., 37: 286–292, 1993.
25. Karp, S. E., Farber, A., Salo, J. C., Hwu, P., Jaffe, G., Asher, A. L., Shiloni, E., Restifo, N. P., Mule, J. J., and Rosenberg, S. A. Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma: tumor inhibition by IL-2 but not tumor necrosis factor. J. Immunol., 150: 896–908, 1993.
26. Yang, J. C., Perry-Lalley, D., and Rosenberg, S. A. An improved method for growing murine tumor-infiltrating lymphocytes with in vivo antitumor activity. J. Biol. Resp. Modif., 9: 149–159, 1990.
27. Hwu, P., Yannelli, J., Kriegler, M., Anderson, W. F., Perez, C., Chiang, Y., Schwarz, S., Cowherd, R., Delgado, C., Mule, J., and Rosenberg, S. A. Functional and molecular characterization of TIL transduced with the TNFα cDNA for the gene therapy of cancer in man. J. Immunol., 150: 4104–4115, 1993.
28. Mule, J. J., Shu, S., Schwarz, S. L., and Rosenberg, S. A. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science (Washington DC), 225: 1487–1489, 1984.
29. Alberti, S., Miotti, S., Fornaro, M., Mantovani, L., Walter, S., Canevari, S., Menard, S., and Colnaghi, M. I. The CA-MOvl8 molecule, a cell-surface marker of human ovarian carcinomas, is anchored to the cell membrane by phosphatidylinositol. Biochem. Biophys. Res. Commun., 171: 1051–1055, 1990.
30. Bénard, J., DaSilva, J., DeBlois, M-C., Boyer, P., Duvillard, P., Chiric, E., and Riou, G. Characterization of a human ovarian adenocarcinoma line IGROV-1, in tissue culture and in nude mice. Cancer Res., 45: 4970–4979, 1985.
31. Romani, L., Mocci, S., Bietta, C., Lanfaloni, L, Puccetti, P., and Bistoni, F. Thl and Th2 cytokine secretion patterns in murine candidiasis: association of Thl responses with acquired resistance. Infect. Immunol., 59: 4647–4654, 1991.
32. Del Prete, G., and Romagnani, S. The role of TH1 and TH2 subsets in human infectious diseases. Trends Microbiol., 2: 4–6, 1994.
33. Reiner, S. L., Wang, Z. E., Hatam, F., Scott, P., and Locksley, R. M. TH1 and TH2 cell antigen receptors in experimental leishmaniasis. Science (Washington DC), 259: 1457–1460, 1993.
34. Locksley, R. M., and Scott, P. Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol. Today, 72: A58-A61, 1991.
35. Street, N. E., and Mosmann, T. R. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J., 5: 171–177, 1991.
36. Barth, R., Mulé, J., Spiess, P., and Rosenberg, S. A. Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes. J. Exp. Med., 173: 647–658, 1991.
37. Schwartzentruber, D. J., Hom, S. S., Dadmarz, R., White, D. E., Yannelli, J. R., Steinberg, S. M., Rosenberg, S. A., and Topalian, S. L. In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2. J. Clin. Oncol., 72: 1475–1483, 1994.
38. Berek, J. S. Epithelial Ovarian Cancer. In: J. S. Berek and N. F. Hacker (eds.), Practical Gynecologic Oncology, pp. 327–375, Baltimore: Williams and Wilkins Co., 1994.